236 related articles for article (PubMed ID: 36508997)
1. Protective effects of CCL01 against Aβ-induced neurotoxicity in 5xFAD transgenic mouse model of Alzheimer's disease.
Ju IG; Son SY; Lee S; Im H; Huh E; Eo H; Choi JG; Sohn MW; Yim SV; Kim SY; Kim DH; Lee CH; Oh MS
Biomed Pharmacother; 2023 Feb; 158():114105. PubMed ID: 36508997
[TBL] [Abstract][Full Text] [Related]
2. MT5-MMP promotes neuroinflammation, neuronal excitability and Aβ production in primary neuron/astrocyte cultures from the 5xFAD mouse model of Alzheimer's disease.
Pilat D; Paumier JM; García-González L; Louis L; Stephan D; Manrique C; Khrestchatisky M; Di Pasquale E; Baranger K; Rivera S
J Neuroinflammation; 2022 Mar; 19(1):65. PubMed ID: 35277173
[TBL] [Abstract][Full Text] [Related]
3. The novel anti-neuroinflammatory functional food CCL01, a mixture of
Hong SM; Ju IG; Kim JH; Park SC; Choi JG; Sohn MW; Oh MS; Kim SY
Food Funct; 2022 Jul; 13(14):7638-7649. PubMed ID: 35735022
[TBL] [Abstract][Full Text] [Related]
4. CCL01, a novel formulation composed of
Ju IG; Hong SM; Yun SW; Huh E; Kim DH; Kim SY; Oh MS
Food Funct; 2021 Nov; 12(21):10690-10699. PubMed ID: 34605514
[TBL] [Abstract][Full Text] [Related]
5. The neuroprotective N-terminal amyloid-β core hexapeptide reverses reactive gliosis and gliotoxicity in Alzheimer's disease pathology models.
Lantz MJ; Roberts AM; Delgado DD; Nichols RA
J Neuroinflammation; 2023 May; 20(1):129. PubMed ID: 37245024
[TBL] [Abstract][Full Text] [Related]
6. BHBA treatment improves cognitive function by targeting pleiotropic mechanisms in transgenic mouse model of Alzheimer's disease.
Wu Y; Gong Y; Luan Y; Li Y; Liu J; Yue Z; Yuan B; Sun J; Xie C; Li L; Zhen J; Jin X; Zheng Y; Wang X; Xie L; Wang W
FASEB J; 2020 Jan; 34(1):1412-1429. PubMed ID: 31914599
[TBL] [Abstract][Full Text] [Related]
7. Cellulose ether treatment inhibits amyloid beta aggregation, neuroinflammation and cognitive deficits in transgenic mouse model of Alzheimer's disease.
Ali T; Klein AN; McDonald K; Johansson L; Mukherjee PG; Hallbeck M; Doh-Ura K; Schatzl HM; Gilch S
J Neuroinflammation; 2023 Jul; 20(1):177. PubMed ID: 37507761
[TBL] [Abstract][Full Text] [Related]
8. A selective p38α/β MAPK inhibitor alleviates neuropathology and cognitive impairment, and modulates microglia function in 5XFAD mouse.
Gee MS; Son SH; Jeon SH; Do J; Kim N; Ju YJ; Lee SJ; Chung EK; Inn KS; Kim NJ; Lee JK
Alzheimers Res Ther; 2020 Apr; 12(1):45. PubMed ID: 32317025
[TBL] [Abstract][Full Text] [Related]
9. Peptide aptamer targeting Aβ-PrP-Fyn axis reduces Alzheimer's disease pathologies in 5XFAD transgenic mouse model.
Ali T; Klein AN; Vu A; Arifin MI; Hannaoui S; Gilch S
Cell Mol Life Sci; 2023 May; 80(6):139. PubMed ID: 37149826
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of microfold cells ameliorates early pathological phenotypes by modulating microglial functions in Alzheimer's disease mouse model.
Kim N; Ju IG; Jeon SH; Lee Y; Jung MJ; Gee MS; Cho JS; Inn KS; Garrett-Sinha LA; Oh MS; Lee JK
J Neuroinflammation; 2023 Nov; 20(1):282. PubMed ID: 38012646
[TBL] [Abstract][Full Text] [Related]
11. Activation of the nuclear receptor PPARδ is neuroprotective in a transgenic mouse model of Alzheimer's disease through inhibition of inflammation.
Malm T; Mariani M; Donovan LJ; Neilson L; Landreth GE
J Neuroinflammation; 2015 Jan; 12():7. PubMed ID: 25592770
[TBL] [Abstract][Full Text] [Related]
12. Theranostic F-SLOH mitigates Alzheimer's disease pathology involving TFEB and ameliorates cognitive functions in Alzheimer's disease models.
Iyaswamy A; Wang X; Krishnamoorthi S; Kaliamoorthy V; Sreenivasmurthy SG; Kumar Durairajan SS; Song JX; Tong BC; Zhu Z; Su CF; Liu J; Cheung KH; Lu JH; Tan JQ; Li HW; Wong MS; Li M
Redox Biol; 2022 May; 51():102280. PubMed ID: 35286997
[TBL] [Abstract][Full Text] [Related]
13. A proteomics analysis of 5xFAD mouse brain regions reveals the lysosome-associated protein Arl8b as a candidate biomarker for Alzheimer's disease.
Boeddrich A; Haenig C; Neuendorf N; Blanc E; Ivanov A; Kirchner M; Schleumann P; Bayraktaroğlu I; Richter M; Molenda CM; Sporbert A; Zenkner M; Schnoegl S; Suenkel C; Schneider LS; Rybak-Wolf A; Kochnowsky B; Byrne LM; Wild EJ; Nielsen JE; Dittmar G; Peters O; Beule D; Wanker EE
Genome Med; 2023 Jul; 15(1):50. PubMed ID: 37468900
[TBL] [Abstract][Full Text] [Related]
14. Low molecular weight chondroitin sulfate ameliorates pathological changes in 5XFAD mice by improving various functions in the brain.
Zhao N; Wu L; Zhang X; Jiang W; Wang F
Neuropharmacology; 2021 Nov; 199():108796. PubMed ID: 34543632
[TBL] [Abstract][Full Text] [Related]
15. Genetic Deletion of Tumor Necrosis Factor-α Attenuates Amyloid-β Production and Decreases Amyloid Plaque Formation and Glial Response in the 5XFAD Model of Alzheimer's Disease.
Paouri E; Tzara O; Zenelak S; Georgopoulos S
J Alzheimers Dis; 2017; 60(1):165-181. PubMed ID: 28826177
[TBL] [Abstract][Full Text] [Related]
16. Butyrylcholinesterase-knockout reduces fibrillar β-amyloid and conserves
DeBay DR; Reid GA; Macdonald IR; Mawko G; Burrell S; Martin E; Bowen CV; Darvesh S
Brain Res; 2017 Sep; 1671():102-110. PubMed ID: 28729192
[TBL] [Abstract][Full Text] [Related]
17. Aerial part of Houttuynia cordata reverses memory impairment by regulating amyloid beta accumulation and neuroinflammation in Alzheimer's disease model.
Ju IG; Lee S; Choi JG; Kim N; Huh E; Lee JK; Oh MS
Phytother Res; 2023 Jul; 37(7):2854-2863. PubMed ID: 36814130
[TBL] [Abstract][Full Text] [Related]
18. Significance of cytosolic cathepsin D in Alzheimer's disease pathology: Protective cellular effects of PLGA nanoparticles against β-amyloid-toxicity.
Wang Y; Wu Q; Anand BG; Karthivashan G; Phukan G; Yang J; Thinakaran G; Westaway D; Kar S
Neuropathol Appl Neurobiol; 2020 Dec; 46(7):686-706. PubMed ID: 32716575
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic effects of non-saponin fraction with rich polysaccharide from Korean red ginseng on aging and Alzheimer's disease.
Shin SJ; Nam Y; Park YH; Kim MJ; Lee E; Jeon SG; Bae BS; Seo J; Shim SL; Kim JS; Han CK; Kim S; Lee YY; Moon M
Free Radic Biol Med; 2021 Feb; 164():233-248. PubMed ID: 33422674
[TBL] [Abstract][Full Text] [Related]
20. PKR knockout in the 5xFAD model of Alzheimer's disease reveals beneficial effects on spatial memory and brain lesions.
Tible M; Mouton Liger F; Schmitt J; Giralt A; Farid K; Thomasseau S; Gourmaud S; Paquet C; Rondi Reig L; Meurs E; Girault JA; Hugon J
Aging Cell; 2019 Jun; 18(3):e12887. PubMed ID: 30821420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
